0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transforming Growth Factor Beta 1 Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-12A244
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Transforming Growth Factor Beta 1 Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Transforming Growth Factor Beta 1 Market Research Report 2026

Code: QYRE-Auto-12A244
Report
2026-03-03
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transforming Growth Factor Beta 1 Market Size

The global Transforming Growth Factor Beta 1 market was valued at US$ 1977 million in 2025 and is anticipated to reach US$ 4088 million by 2032, at a CAGR of 11.1% from 2026 to 2032.

Transforming Growth Factor Beta 1 Market

Transforming Growth Factor Beta 1 Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transforming Growth Factor Beta 1 competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
This report delivers a comprehensive overview of the global Transforming Growth Factor Beta 1 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transforming Growth Factor Beta 1. The Transforming Growth Factor Beta 1 market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Transforming Growth Factor Beta 1 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Transforming Growth Factor Beta 1 Market Report

Report Metric Details
Report Name Transforming Growth Factor Beta 1 Market
Accounted market size in 2025 US$ 1977 million
Forecasted market size in 2032 US$ 4088 million
CAGR 11.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Pirfenidone
  • Galunisertib
  • Others
by Application
  • IPF
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Transforming Growth Factor Beta 1 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Transforming Growth Factor Beta 1 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Transforming Growth Factor Beta 1 Market growing?

Ans: The Transforming Growth Factor Beta 1 Market witnessing a CAGR of 11.1% during the forecast period 2026-2032.

What is the Transforming Growth Factor Beta 1 Market size in 2032?

Ans: The Transforming Growth Factor Beta 1 Market size in 2032 will be US$ 4088 million.

What is the Transforming Growth Factor Beta 1 Market share by region?

Ans: In humans, TGF-β1 is encoded by the TGFB1 gene North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.

Who are the main players in the Transforming Growth Factor Beta 1 Market report?

Ans: The main players in the Transforming Growth Factor Beta 1 Market are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG

What are the Application segmentation covered in the Transforming Growth Factor Beta 1 Market report?

Ans: The Applications covered in the Transforming Growth Factor Beta 1 Market report are IPF, Cancer, Others

What are the Type segmentation covered in the Transforming Growth Factor Beta 1 Market report?

Ans: The Types covered in the Transforming Growth Factor Beta 1 Market report are Pirfenidone, Galunisertib, Others

1 Transforming Growth Factor Beta 1 Market Overview
1.1 Product Definition
1.2 Transforming Growth Factor Beta 1 by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Value by Type: 2025 vs 2032
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Transforming Growth Factor Beta 1 by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Value by Application: 2025 vs 2032
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
1.4.1 Global Transforming Growth Factor Beta 1 Revenue 2021–2032
1.4.2 Global Transforming Growth Factor Beta 1 Sales 2021–2032
1.4.3 Global Transforming Growth Factor Beta 1 Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Transforming Growth Factor Beta 1 Market Competition by Manufacturers
2.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2021–2026)
2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Transforming Growth Factor Beta 1, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Transforming Growth Factor Beta 1, Product Types and Applications
2.7 Global Key Manufacturers of Transforming Growth Factor Beta 1, Date of Entry into the Industry
2.8 Global Transforming Growth Factor Beta 1 Market Competitive Situation and Trends
2.8.1 Global Transforming Growth Factor Beta 1 Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Transforming Growth Factor Beta 1 Players Market Share by Revenue
2.8.3 Global Transforming Growth Factor Beta 1 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transforming Growth Factor Beta 1 Market Scenario by Region
3.1 Global Transforming Growth Factor Beta 1 Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2021–2032
3.2.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2021–2026
3.2.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2027–2032
3.3 Global Transforming Growth Factor Beta 1 Revenue by Region: 2021–2032
3.3.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2021–2026
3.3.2 Global Transforming Growth Factor Beta 1 Revenue by Region: 2027–2032
3.4 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.4.1 North America Transforming Growth Factor Beta 1 Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Transforming Growth Factor Beta 1 Sales by Country (2021–2032)
3.4.3 North America Transforming Growth Factor Beta 1 Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.5.1 Europe Transforming Growth Factor Beta 1 Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2021–2032)
3.5.3 Europe Transforming Growth Factor Beta 1 Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Region
3.6.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2021–2032)
3.6.3 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.7.1 Latin America Transforming Growth Factor Beta 1 Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Transforming Growth Factor Beta 1 Sales by Country (2021–2032)
3.7.3 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2021–2032)
3.8.3 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transforming Growth Factor Beta 1 Sales by Type (2021–2032)
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2021–2026)
4.1.2 Global Transforming Growth Factor Beta 1 Sales by Type (2027–2032)
4.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021–2032)
4.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2021–2032)
4.2.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2021–2026)
4.2.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2027–2032)
4.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021–2032)
4.3 Global Transforming Growth Factor Beta 1 Price by Type (2021–2032)
5 Segment by Application
5.1 Global Transforming Growth Factor Beta 1 Sales by Application (2021–2032)
5.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2021–2026)
5.1.2 Global Transforming Growth Factor Beta 1 Sales by Application (2027–2032)
5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021–2032)
5.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2021–2032)
5.2.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2021–2026)
5.2.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2027–2032)
5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021–2032)
5.3 Global Transforming Growth Factor Beta 1 Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Shionogi Ltd
6.2.1 Shionogi Ltd Company Information
6.2.2 Shionogi Ltd Description and Business Overview
6.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
6.2.5 Shionogi Ltd Recent Developments/Updates
6.3 Acceleron Pharma Inc
6.3.1 Acceleron Pharma Inc Company Information
6.3.2 Acceleron Pharma Inc Description and Business Overview
6.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
6.3.5 Acceleron Pharma Inc Recent Developments/Updates
6.4 Genzyme Corp
6.4.1 Genzyme Corp Company Information
6.4.2 Genzyme Corp Description and Business Overview
6.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
6.4.5 Genzyme Corp Recent Developments/Updates
6.5 Isarna Therapeutics GmbH
6.5.1 Isarna Therapeutics GmbH Company Information
6.5.2 Isarna Therapeutics GmbH Description and Business Overview
6.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
6.5.5 Isarna Therapeutics GmbH Recent Developments/Updates
6.6 Scholar Rock
6.6.1 Scholar Rock Company Information
6.6.2 Scholar Rock Description and Business Overview
6.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
6.6.5 Scholar Rock Recent Developments/Updates
6.7 Sirnaomics Inc
6.7.1 Sirnaomics Inc Company Information
6.7.2 Sirnaomics Inc Description and Business Overview
6.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.7.5 Sirnaomics Inc Recent Developments/Updates
6.8 Eli Lilly and Co
6.8.1 Eli Lilly and Co Company Information
6.8.2 Eli Lilly and Co Description and Business Overview
6.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
6.8.5 Eli Lilly and Co Recent Developments/Updates
6.9 Formation Biologics Inc
6.9.1 Formation Biologics Inc Company Information
6.9.2 Formation Biologics Inc Description and Business Overview
6.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.9.5 Formation Biologics Inc Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Company Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transforming Growth Factor Beta 1 Industry Chain Analysis
7.2 Transforming Growth Factor Beta 1 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transforming Growth Factor Beta 1 Production Mode & Process Analysis
7.4 Transforming Growth Factor Beta 1 Sales and Marketing
7.4.1 Transforming Growth Factor Beta 1 Sales Channels
7.4.2 Transforming Growth Factor Beta 1 Distributors
7.5 Transforming Growth Factor Beta 1 Customer Analysis
8 Transforming Growth Factor Beta 1 Market Dynamics
8.1 Transforming Growth Factor Beta 1 Industry Trends
8.2 Transforming Growth Factor Beta 1 Market Drivers
8.3 Transforming Growth Factor Beta 1 Market Challenges
8.4 Transforming Growth Factor Beta 1 Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Transforming Growth Factor Beta 1 Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Transforming Growth Factor Beta 1 Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Transforming Growth Factor Beta 1 Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Transforming Growth Factor Beta 1 Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Transforming Growth Factor Beta 1 Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Transforming Growth Factor Beta 1, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Transforming Growth Factor Beta 1, Product Types and Applications
 Table 12. Global Key Manufacturers of Transforming Growth Factor Beta 1, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Transforming Growth Factor Beta 1 Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transforming Growth Factor Beta 1 Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Transforming Growth Factor Beta 1 Sales by Region (K Units), 2021–2026
 Table 18. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021–2026)
 Table 19. Global Transforming Growth Factor Beta 1 Sales by Region (K Units), 2027–2032
 Table 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2027–2032)
 Table 21. Global Transforming Growth Factor Beta 1 Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021–2026)
 Table 23. Global Transforming Growth Factor Beta 1 Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2027–2032)
 Table 25. North America Transforming Growth Factor Beta 1 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Transforming Growth Factor Beta 1 Sales by Country (K Units), 2021–2026
 Table 27. North America Transforming Growth Factor Beta 1 Sales by Country (K Units), 2027–2032
 Table 28. North America Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Transforming Growth Factor Beta 1 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Transforming Growth Factor Beta 1 Sales by Country (K Units), 2021–2026
 Table 32. Europe Transforming Growth Factor Beta 1 Sales by Country (K Units), 2027–2032
 Table 33. Europe Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Transforming Growth Factor Beta 1 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Transforming Growth Factor Beta 1 Sales by Country (K Units), 2021–2026
 Table 42. Latin America Transforming Growth Factor Beta 1 Sales by Country (K Units), 2027–2032
 Table 43. Latin America Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Transforming Growth Factor Beta 1 Sales (K Units) by Type (2021–2026)
 Table 51. Global Transforming Growth Factor Beta 1 Sales (K Units) by Type (2027–2032)
 Table 52. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021–2026)
 Table 53. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2027–2032)
 Table 54. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021–2026)
 Table 57. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2027–2032)
 Table 58. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Transforming Growth Factor Beta 1 Sales (K Units) by Application (2021–2026)
 Table 61. Global Transforming Growth Factor Beta 1 Sales (K Units) by Application (2027–2032)
 Table 62. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021–2026)
 Table 63. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2027–2032)
 Table 64. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021–2026)
 Table 67. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2027–2032)
 Table 68. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Transforming Growth Factor Beta 1 Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Shionogi Ltd Company Information
 Table 76. Shionogi Ltd Description and Business Overview
 Table 77. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Shionogi Ltd Transforming Growth Factor Beta 1 Product
 Table 79. Shionogi Ltd Recent Developments/Updates
 Table 80. Acceleron Pharma Inc Company Information
 Table 81. Acceleron Pharma Inc Description and Business Overview
 Table 82. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product
 Table 84. Acceleron Pharma Inc Recent Developments/Updates
 Table 85. Genzyme Corp Company Information
 Table 86. Genzyme Corp Description and Business Overview
 Table 87. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Genzyme Corp Transforming Growth Factor Beta 1 Product
 Table 89. Genzyme Corp Recent Developments/Updates
 Table 90. Isarna Therapeutics GmbH Company Information
 Table 91. Isarna Therapeutics GmbH Description and Business Overview
 Table 92. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product
 Table 94. Isarna Therapeutics GmbH Recent Developments/Updates
 Table 95. Scholar Rock Company Information
 Table 96. Scholar Rock Description and Business Overview
 Table 97. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Scholar Rock Transforming Growth Factor Beta 1 Product
 Table 99. Scholar Rock Recent Developments/Updates
 Table 100. Sirnaomics Inc Company Information
 Table 101. Sirnaomics Inc Description and Business Overview
 Table 102. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Sirnaomics Inc Transforming Growth Factor Beta 1 Product
 Table 104. Sirnaomics Inc Recent Developments/Updates
 Table 105. Eli Lilly and Co Company Information
 Table 106. Eli Lilly and Co Description and Business Overview
 Table 107. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Eli Lilly and Co Transforming Growth Factor Beta 1 Product
 Table 109. Eli Lilly and Co Recent Developments/Updates
 Table 110. Formation Biologics Inc Company Information
 Table 111. Formation Biologics Inc Description and Business Overview
 Table 112. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Formation Biologics Inc Transforming Growth Factor Beta 1 Product
 Table 114. Formation Biologics Inc Recent Developments/Updates
 Table 115. Novartis AG Company Information
 Table 116. Novartis AG Description and Business Overview
 Table 117. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Novartis AG Transforming Growth Factor Beta 1 Product
 Table 119. Novartis AG Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Transforming Growth Factor Beta 1 Distributors List
 Table 123. Transforming Growth Factor Beta 1 Customers List
 Table 124. Transforming Growth Factor Beta 1 Market Trends
 Table 125. Transforming Growth Factor Beta 1 Market Drivers
 Table 126. Transforming Growth Factor Beta 1 Market Challenges
 Table 127. Transforming Growth Factor Beta 1 Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transforming Growth Factor Beta 1
 Figure 2. Global Transforming Growth Factor Beta 1 Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Transforming Growth Factor Beta 1 Market Share by Type: 2025 & 2032
 Figure 4. Pirfenidone Product Picture
 Figure 5. Galunisertib Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Transforming Growth Factor Beta 1 Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Transforming Growth Factor Beta 1 Market Share by Application: 2025 & 2032
 Figure 9. IPF
 Figure 10. Cancer
 Figure 11. Others
 Figure 12. Global Transforming Growth Factor Beta 1 Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Transforming Growth Factor Beta 1 Market Size (US$ Million), 2021–2032
 Figure 14. Global Transforming Growth Factor Beta 1 Sales (K Units), 2021–2032
 Figure 15. Global Transforming Growth Factor Beta 1 Average Price (USD/Unit), 2021–2032
 Figure 16. Transforming Growth Factor Beta 1 Report Years Considered
 Figure 17. Transforming Growth Factor Beta 1 Sales Share by Manufacturers in 2025
 Figure 18. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Transforming Growth Factor Beta 1 Players: Market Share by Revenue in Transforming Growth Factor Beta 1 in 2025
 Figure 20. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2021–2032)
 Figure 23. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2021–2032)
 Figure 27. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021–2032)
 Figure 35. China Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Transforming Growth Factor Beta 1 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Transforming Growth Factor Beta 1 by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Transforming Growth Factor Beta 1 by Type (2021–2032)
 Figure 56. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Transforming Growth Factor Beta 1 by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Transforming Growth Factor Beta 1 by Application (2021–2032)
 Figure 59. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2021–2032)
 Figure 60. Transforming Growth Factor Beta 1 Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners